These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 8670271

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The WW domain of dystrophin requires EF-hands region to interact with beta-dystroglycan.
    Rentschler S, Linn H, Deininger K, Bedford MT, Espanel X, Sudol M.
    Biol Chem; 1999 Apr; 380(4):431-42. PubMed ID: 10355629
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. WW and EF hand domains of dystrophin-family proteins mediate dystroglycan binding.
    Chung W, Campanelli JT.
    Mol Cell Biol Res Commun; 1999 Apr; 2(3):162-71. PubMed ID: 10662592
    [Abstract] [Full Text] [Related]

  • 5. Interactions between dystrophin and the sarcolemma membrane.
    Chamberlain JS, Corrado K, Rafael JA, Cox GA, Hauser M, Lumeng C.
    Soc Gen Physiol Ser; 1997 Apr; 52():19-29. PubMed ID: 9210217
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A 5' dystrophin duplication mutation causes membrane deficiency of alpha-dystroglycan in a family with X-linked cardiomyopathy.
    Bies RD, Maeda M, Roberds SL, Holder E, Bohlmeyer T, Young JB, Campbell KP.
    J Mol Cell Cardiol; 1997 Dec; 29(12):3175-88. PubMed ID: 9441825
    [Abstract] [Full Text] [Related]

  • 8. Direct interaction of beta-dystroglycan with F-actin.
    Chen YJ, Spence HJ, Cameron JM, Jess T, Ilsley JL, Winder SJ.
    Biochem J; 2003 Oct 15; 375(Pt 2):329-37. PubMed ID: 12892561
    [Abstract] [Full Text] [Related]

  • 9. Dystroglycan glycosylation and its role in matrix binding in skeletal muscle.
    Martin PT.
    Glycobiology; 2003 Aug 15; 13(8):55R-66R. PubMed ID: 12736199
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Towards an understanding of the dystrophin-glycoprotein complex: linkage between the extracellular matrix and the membrane cytoskeleton in muscle fibers.
    Ohlendieck K.
    Eur J Cell Biol; 1996 Jan 15; 69(1):1-10. PubMed ID: 8825019
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Structural and functional analysis of the N-terminal extracellular region of beta-dystroglycan.
    Di Stasio E, Sciandra F, Maras B, Di Tommaso F, Petrucci TC, Giardina B, Brancaccio A.
    Biochem Biophys Res Commun; 1999 Dec 09; 266(1):274-8. PubMed ID: 10581202
    [Abstract] [Full Text] [Related]

  • 18. Ultrastructural localization of adhalin, alpha-dystroglycan and merosin in normal and dystrophic muscle.
    Cullen MJ, Walsh J, Roberds SL, Campbell KP.
    Neuropathol Appl Neurobiol; 1996 Feb 09; 22(1):30-7. PubMed ID: 8866780
    [Abstract] [Full Text] [Related]

  • 19. Beta1 integrin and alpha-dystroglycan binding sites are localized to different laminin-G-domain-like (LG) modules within the laminin alpha5 chain G domain.
    Yu H, Talts JF.
    Biochem J; 2003 Apr 15; 371(Pt 2):289-99. PubMed ID: 12519075
    [Abstract] [Full Text] [Related]

  • 20. In vitro developmental expression of dystroglycan and laminin-alpha2 in human skeletal muscle.
    Chen L, Burgunder JM.
    Cell Biol Int; 2005 Jul 15; 29(7):506-13. PubMed ID: 15982904
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.